Dr. Mohammad A. Alsoub, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 39
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 640
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
TN license 38437 -
Critical Care Medicine (Internal Medicine) Physician
TN license 38437
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Tristar Horizon Medical Center Dickson, TN
- Ascension Saint Thomas Three Rivers Waverly, TN
Medical groups
- Dickson Medical Associates, PC (56 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 640
- Services billed
- 1,421
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 318 | 242 |
| Established patient office or other outpatient visit, 30-39 minutes | 133 | 106 |
| Sleep study in sleep lab (6 years or older) | 123 | 122 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 117 | 68 |
| New patient office or other outpatient visit, 45-59 minutes | 104 | 104 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 103 | 93 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 88 | 88 |
| Critical care, first 30-74 minutes | 87 | 34 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 58 | 58 |
| Test to examine how well the lungs exchange gases | 55 | 55 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Potassium Chloride Other prescribers in Dickson, TN | 475 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Dickson, TN | 419 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Dickson, TN | 410 |
| Furosemide Other prescribers in Dickson, TN | 375 |
| Divalproex Sodium Other prescribers in Dickson, TN | 372 |
| Eliquis (apixaban) Other prescribers in Dickson, TN | 370 |
| Atorvastatin Calcium Other prescribers in Dickson, TN | 357 |
| Sertraline Hcl Other prescribers in Dickson, TN | 356 |
| Trazodone Hcl Other prescribers in Dickson, TN | 295 |
| Prednisone Other prescribers in Dickson, TN | 287 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 24 companies reported 114 payments worth $2,343 in total to this clinician.
| Ethicon Inc. | $310 |
|---|---|
| Inspire Medical Systems, Inc. | $265 |
| GlaxoSmithKline, LLC. | $249 |
| AstraZeneca Pharmaceuticals LP | $205 |
| Viatris Specialty LLC | $187 |
| Regeneron Healthcare Solutions, Inc. | $172 |
| Genzyme Corporation | $172 |
| Actelion Pharmaceuticals US, Inc. | $162 |
| Food and Beverage | $2,178 |
|---|---|
| Education | $165 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. Jul 20, 2025 | Education OPSUMIT; UPTRAVI · Cardiology · in-kind | $89.99 |
| Sanofi-aventis U.S. LLC Mar 24, 2025 | Education DUPIXENT · Immunology · in-kind | $57.48 |
| Insmed, Inc. Sep 17, 2025 | Education Brinsupri; Brinsupri · Respiratory · in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $34,405 in research payments for these studies, mostly to the institutions running them.
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Cumberland Pharmaceuticals, Inc. · Recruiting · NCT05571059 - Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation
Sanofi US Services Inc. · Completed · NCT04456673
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.